Key result
Targeted therapy and lifestyle modifications linked to improved post-COVID autonomic dysfunction in a case report.
Case Report (n=1)
No
COVID-19 may trigger long-term autonomic dysfunction and autoimmune thyroiditis, which can improve with targeted therapy and lifestyle modifications.
Introduction: We present a case of Hashimoto's thyroiditis and severe autonomic dysfunction three months after the resolution of the acute phase of COVID-19 infection in a patient with no prior thyroid disease and autonomic dysfunction. Patient Review: We discuss our patient's clinical presentation, diagnostic evaluation, and subsequent management and follow-up. The patient had previously tested positive for COVID-19. A 53-year-old female developed Hashimoto's thyroiditis with normal thyroid function and severe autonomic dysfunction. Her heart rate variability (HRV) is depressed, and her High-Frequency power (HF) is high. Conclusion: Our findings suggest that COVID-19 could have long-term negative effects on antithyroid antibodies. Therefore, testing antithyroid antibodies should be included in the follow-up algorithm for COVID-19 survivors. Autonomic nervous system dysfunction related to COVID-19 may be reversible and early aggressive therapy is necessary. The new technique is important for the early detection of post-acute sequelae of SARS-CoV-2 infection (PASC) in the autonomic nervous system.
No takes yet. Share an insight, caveat, or question.
Milić et al. (2025) conducted a case report in Severe autonomic dysfunction and Hashimoto's thyroiditis (n=1). COVID-19 infection was evaluated on Autonomic nervous system function and thyroid status. A 53-year-old female developed severe autonomic dysfunction and Hashimoto's thyroiditis three months after COVID-19, which improved after three years of targeted therapy and lifestyle modifications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: